ReviewCytoJournal2026
Current situation and future prospect of biobank.
Review in CytoJournal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biobanks are essential infrastructures dedicated to the systematic collection, processing, storage, and distribution of biological samples and related data, serving as fundamental resources for biomedical research. Their application ranges from clinical research and epidemiological investigations to public health monitoring, facilitating the identification of disease-associated genetic variations and the exploration of gene-environment interactions. Biobanks provide valuable resources for systems biology and interdisciplinary research, significantly broadening the scope and depth of scientific inquiry. This review explores the development history, current landscape, and future prospects of global biobanking initiatives, highlighting notable advancements in technological innovation and methodological practices. It also scrutinizes prevailing challenges and envisions future trajectories for development. In the era of personalized medicine, biobanks are expected to play a more critical role by providing the data and samples needed for the development of individualized therapies. By surmounting existing impediments and fostering international collaboration, biobanks are poised to propel scientific breakthroughs and elevate global healthcare standards. This article aims to comprehensively elucidate the trajectory of biobanking development and its profound influence on biomedical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.